CDASH

Introduction

CDASH: The Clinical Data Acquisition Standards Harmonization Implementation Guide (CDASHIG) establishes a standard way to collect data consistently across studies and sponsors so that data collection formats and structures provide clear traceability of submission data into the SDTM, delivering more transparency to regulators and others who conduct data review. The following videos introduce you to the CDASH model and the CDASHIG.


Versions

The latest versions of the Clinical Data Acquisition Standards Harmonization Implementation Guides (CDASHIGs) have been developed in reference to a specific CDASH model. However, the CDASH model is cumulative – each new release builds on the previous model. Therefore, the models are considered backward compatible.

Therapeutic Area User Guides

Therapeutic Area User Guides (TAUGs) extend the Foundational Standards to represent data that pertains to specific disease areas. TAUGs include disease-specific metadata, examples and guidance on implementing CDISC standards for a variety of uses, including global regulatory submissions. The following video will introduce you to TAUGs and how they relate to CDISC Foundational Standards.

Controlled Terminology

Controlled Terminology is the set of codelists and valid values used with data items within CDISC-defined datasets. The following video introduces you to CDISC Controlled Terminology and how it is used with CDISC standards.

Traceability

Traceability is a fundamental element of data quality and a requirement for studies submitted to regulatory authorities. From data collection to final analysis, traceability plays a crucial role in ensuring the integrity of source data and in reinforcing clinical research results. The following video provides an introduction to implementing traceability in CDISC-compliant studies.

Regulatory Requirements

CDISC standards are required or recommended by several global regulatory agencies. Standardized data enables regulators to streamline the review process with a more consistent use of analysis tools to better view drug data and highlight areas of concern. The following video introduces you to regulatory requirements and the use of CDISC standards.

Team Guiding Principles

Standards in Development

Foundational

For current versions of the standards, please visit the Standards Home Page.


Standard Sort descending Release Notes Projected Publication
ADaM Metadata Submission Guidelines v1.0

Resolving Public Comments.

2023
ADaM Oncology Examples

Resolving Public Comments.

2023
ADaM popPK Implementation Guide v1.0

Resolving Public Comments.

2023
Analysis Results Metadata (ARM) Conformance Rules

In Development.

2023
Analysis Results Standard v1.0

In Development.

2023
CDASH v1.3

In Development.

2023
CDASHIG v2.3

In Development.

2023
Safety User Guide v1.0

In Development.

2023
SDTM for Observational Studies v1.0

In Development.

2023
SDTM v2.1

In Development.

2023
SEND Tumor Combinations v1.0

Resolving Public Comments.

2023
SENDIG v4.0

In Development.

2023
SENDIG-DART v1.2

Resolving Public Comments.

2023
SENDIG-Genotoxicity v1.0

Resolving Public Comments.

2023
Tobacco Implementation Guide v1.0

In Development.

2023

Data Exchange

For current versions of the Data Exchange standards, please visit the Data Exchange Page.


Standard Sort descending Release Notes Projected Publication
ODM v2.0

Resolving Public Comments.

2023

Therapeutic Areas

For current versions of the Therapeutic Area (TA) standards, please visit the TA Home Page.


Therapeutic Area Sort descending Release Notes Projected Publication
COVID-19 Therapeutic Area User Guide v2.0

In Development.

2023
Rare Diseases Therapeutic Area User Guide

In Development.

2023
Traditional Chinese Medicine - Acupuncture Therapeutic Area User Guide v1.0

Resolving Public Comments.

2023

Knowledge Base